Database Sponors
Novartis Oncology
Novartis Oncology provide a broad range of innovative therapies and
practical solutions that improve and extend the lives of cancer patients. Every
day, around the world we are exploring and pioneering new treatments that are
likely to transform the way cancer is treated.
Our current portfolio includes:
-
Glivec, which has set a new standard in the treatment of
CML and GIST;
-
Femara, a first-line treatment for postmenopausal women
with hormone dependant early and advanced breast cancer;
-
Zometa, for multiple myeloma and for malignancies involving
bone, including breast, prostate and lung cancers, as well as the treatment of
hypercalcaemia of malignancy;
-
Sandostatin LAR for the symptomatic control and reduction
of GH and IGF-1 in patients with active acromegaly and to control symptoms in
patients with functional carcinoid tumours and VIPomas; and
-
Exjade, a once-daily, oral, iron chelator for the treatment
of iron overload in patients receiving frequent blood transfusions.
|
 |
Cancer Institute
NSW
The Cancer Institute NSW is Australia's first State-wide Government
cancer control agency.
It was established in July 2003 through the Cancer Institute NSW Act 2003 to
help further reduce the impact of cancer. The Cancer Institute NSW is
responsible for reducing cancer incidence, increasing cancer survival,
improving the quality of life for cancer patients and their carers and
providing expert advice on cancer.
|
 |
Johnson & Johnson
Johnson & Johnson is the world's most comprehensive and broadly based
manufacturer of health care products as well as provider of related services
for the consumer, pharmaceutical and medical and diagnostics markets.
We believe our first responsibility is to the doctors, nurses, patients,
mothers, fathers and all others who use our products and services.
Johnson & Johnson has achieved leadership by concentrating on a unique form
of decentralised management, following the ethical principles embodied in our
Credo and managing the business for the long term.
The Medical Devices and Diagnostics segment of J&J includes a broad range
of products used principally in the professional fields by physicians, nurses,
therapists, hospitals, diagnostic laboratories and clinics. The medical device
companies of the Johnson & Johnson Family of Companies develop, market and
sell more medical devices than any other company in the world.
In Australia, Johnson & Johnson Medical is the leading supplier of medical
devices. Our business includes brands such as Ethicon, Ethicon Endosurgery,
Cordis, DePuy and ASP. Our products cover a wide spectrum of devices, ranging
from sutures, wound management, surgical stapling and minimally invasive
laparoscopic instruments to neurovascular, endovascular and cardiology
equipment and orthopaedic products such as hips, knees, fingers and shoulder
implants.
|
 |
Home > Corporates > Database Sponors
